Evelo Biosciences Inc (EVLO PINK) stock market data APIs
$0.0005
0(0%)
as of January 14, 2025
Evelo Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Prev. Close
0.0005
Open
0.0005
Volume
367
High
0.0005
Low
0.0005
52 wk Range
0.0001-0.0729
Market Cap
28 474
Shares Outstanding
18 983 K
Revenue
0
EPS
-0.7112
Beta
1.304
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evelo Biosciences Inc data using free add-ons & libraries
Get Evelo Biosciences Inc Fundamental Data
Evelo Biosciences Inc Fundamental data includes:
- Net Revenue: 0
- EBITDA: -69 674 000
- Earnings Per Share: -15
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-11-09
- EPS/Forecast: -0.97
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evelo Biosciences Inc News
New
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Greetings, and welcome to Horizon Technology Finance Corporation Third Quarter 2023 Ea...
Q3 2023 Horizon Technology Finance Corp Earnings Call
Participants Daniel Raffaele Trolio; Executive VP, CFO & Treasurer; Horizon Technology Finance Corporation Gerald A. Michaud; President & Director; Horizon Technology Finance Corporation Megan N. B...
Evelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study
Shares of Evelo Biosciences EVLO plummeted 58.8% on Tuesday after its management announced disappointing top-line results from a mid-stage study evaluating EDP2939 in moderate psoriasis. The mid-stag...
Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More
It was a busy week for the biotech sector before the third-quarter earnings kicked in. While nothing important came from bigwigs, pipeline and regulatory updates from quite a few other biotechs were i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
